Abstract Temporal changes in the avoidance responses and serum prolactin levels were investigated for a 360 min period after s.c. administration of antipsychotic drugs such as chlorpromazine (2 mg/kg), prochlorperazine (2 mg/kg), haloperidol (0.035 mg/kg), droperidol (0.03 mg/kg), YM-09151-2 (0.005 mg/kg) and sulpiride (80 mg/kg) in rats. Male adult rats of the Wistar strain were trained under a continuous lever-press avoidance schedule (Sidman type) to observe avoidancesuppressing effects of the drugs. The avoidance response was suppressed after administration of chlorpromazine, prochlorperazine, haloperidol, droperidol and YM-09151-2, showing significant decrease in response rate and significant increase in shock rate when compared with those after saline administration, while it was scarcely suppressed within 150 min after sulpiride. On the other hand, serum prolactin levels were increased after administration of all the drugs used. Furthermore, parallelism between temporal changes in the avoidance responses and those in serum prolactin levels was observed after administration of the antipsychotic drugs, except for sulpiride. These results suggest that the prolactin-increasing effects of antipsychotic drugs are applicable for predicting antipsychotic efficacies in humans, excluding sulpiride therapy.
Conditioned avoidance responses of rats have been widely applied to preclinical tests of antipsychotic drugs because of the high correlation between the avoidancesuppressing effects observed in animals and antipsychotic potencies in man (1, 2).
On the other hand, prolactin secretion is markedly stimulated by the antipsychotic drugs in animals and man (3-6). It is, therefore, important to investigate the relationship between avoidance-suppressing and prolactin-increasing effects of the antipsychotic drugs. However, there are few reports concerned with this problem.
In the present study, the systematic correlation between temporal changes in avoidance response and those in serum prolactin level was investigated after administration of antipsychotic drugs such as phenothiazine, butyrophenone and benzamide derivatives in rats. 0.005 mg/kg; and sulpiride (SP) (DogmatylR, Inj., Fujisawa), 80 mg/kg were used. According to our reports, the doses used were optimum for observing typical avoidance-suppressing effect without cataleptic symptom in rats (10-12).
Materials and Methods
YM-09151-2 (cis-N-(1-benzy1-2-methylpyrrolidi n -3-yl) -5-chloro-2-methoxy-4-methylarninobenzamide), one of the benzamide derivatives which induce strong avoidance suppression (12, 13), was dissolved in a few drops of 1N HCI with subsequent dilution with saline solution. CPZ, PCZ, HPD and DPD were dissolved in saline solution. The commercial preparation of SP was used without any treatment. Doses were made up to the volume of 1 ml/kg of body weight, except in the case of SP (1.6 ml/kg).
Statistical analysis: Results obtained were analyzed by one way ANOVA followed by Student's t-test. They were considered significant when P was equal to or less than 0.05.
Results
The was elicited very slowly, and it was observed at 150 min after the administration and thereafter, while the serum prolactin level was rapidly elevated after the drug administration. It is well known that SP, a D2 blocking agent (22) , elicits little effect on avoidance responses (11-13). Kuribara and Tadokoro (11) investigated the avoidance-suppressing effects of 28 kinds of antipsychotic drugs on both continuous and discriminated avoidance responses in rats over a 120 min period. In these experiments, little avoidance-suppressing effect of SP was seen independently of the experimental schedules used. The similar effect of SP on discriminated avoidance response was also reported by Usuda et al. (13) .
On the other hand, Honda et al. (23) investigated apomorphineand methamphetamine-induced gnawing and rotational behaviors in naive and in substantia nigralesioned rats, respectively, after oral and intraventricular administration of CPZ, H PD and SP. In this study, they reported that SP had essentially a potent inhibitory effect on dopaminergic neurons in the brain and that the weak central effects of SP given peripherally might be due to poor penetration through the blood-brain barrier. This hypothesis is also confirmed by the investigations of Hopf and Dross (24) and Benakis and Rey (25) . These possibilities indicate that the slow onset of the avoidance-suppressing effect of SP observed in the present study is probably not due to the experimental procedure used, but rather due to the ability of the drug to hardly cross the blood-brain barrier. Actually, YM (a similar D2 blocking agent that is a benzamide derivative), (22) which can readily pass through the barrier and exhibits potent avoidance-suppressing effect (12, 13), showed almost parallel avoidance suppression to the increase in serum prolactin level in the present study.
There are many reports which emphasize the potent effect of SP on prolactin secretion both in serum and cerebrospinal fluid in animals and psychotic patients (26). This The data are shown in the same way as in Fig. 1. effect is thought to be due to a direct stereospecific blockade of dopamine receptors in the anterior pituitary gland (27) (28) (29) (30) .
The results obtained in the present study also indicate that the prolactin-increasing effect of antipsychotic drugs may be utilized as a determinant to predict antipsychotic potencies in human cases, excluding sulpiride treatment, even though hyperprolactinemia is one of the noticeable side effects in antipsychotic therapy. The data are shown in the same way as in Fig. 1 
